Global Hepatitis B and C Diagnostics Market Research Report 2023

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

The global Hepatitis B and C Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.

This report aims to provide a comprehensive presentation of the global market for Hepatitis B and C Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B and C Diagnostics.

The Hepatitis B and C Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hepatitis B and C Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hepatitis B and C Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Hepatitis B

1.2.3 Hepatitis C

1.3 Market by Application

1.3.1 Global Hepatitis B and C Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Immunodiagnostics

1.3.3 Nucleic Acid Test (NAT)

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Hepatitis B and C Diagnostics Market Perspective (2018-2029)

2.2 Hepatitis B and C Diagnostics Growth Trends by Region

2.2.1 Global Hepatitis B and C Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Hepatitis B and C Diagnostics Historic Market Size by Region (2018-2023)

2.2.3 Hepatitis B and C Diagnostics Forecasted Market Size by Region (2024-2029)

2.3 Hepatitis B and C Diagnostics Market Dynamics

2.3.1 Hepatitis B and C Diagnostics Industry Trends

2.3.2 Hepatitis B and C Diagnostics Market Drivers

2.3.3 Hepatitis B and C Diagnostics Market Challenges

2.3.4 Hepatitis B and C Diagnostics Market Restraints

3.1 Global Top Hepatitis B and C Diagnostics Players by Revenue

3.1.1 Global Top Hepatitis B and C Diagnostics Players by Revenue (2018-2023)

3.1.2 Global Hepatitis B and C Diagnostics Revenue Market Share by Players (2018-2023)

3.2 Global Hepatitis B and C Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hepatitis B and C Diagnostics Revenue

3.4 Global Hepatitis B and C Diagnostics Market Concentration Ratio

3.4.1 Global Hepatitis B and C Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B and C Diagnostics Revenue in 2022

3.5 Hepatitis B and C Diagnostics Key Players Head office and Area Served

3.6 Key Players Hepatitis B and C Diagnostics Product Solution and Service

3.7 Date of Enter into Hepatitis B and C Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Hepatitis B and C Diagnostics Historic Market Size by Type (2018-2023)

4.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2024-2029)

5.1 Global Hepatitis B and C Diagnostics Historic Market Size by Application (2018-2023)

5.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2024-2029)

6.1 North America Hepatitis B and C Diagnostics Market Size (2018-2029)

6.2 North America Hepatitis B and C Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Hepatitis B and C Diagnostics Market Size by Country (2018-2023)

6.4 North America Hepatitis B and C Diagnostics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Hepatitis B and C Diagnostics Market Size (2018-2029)

7.2 Europe Hepatitis B and C Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Hepatitis B and C Diagnostics Market Size by Country (2018-2023)

7.4 Europe Hepatitis B and C Diagnostics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size (2018-2029)

8.2 Asia-Pacific Hepatitis B and C Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2018-2023)

8.4 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Hepatitis B and C Diagnostics Market Size (2018-2029)

9.2 Latin America Hepatitis B and C Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Hepatitis B and C Diagnostics Market Size by Country (2018-2023)

9.4 Latin America Hepatitis B and C Diagnostics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size (2018-2029)

10.2 Middle East & Africa Hepatitis B and C Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2018-2023)

10.4 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Detail

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Hepatitis B and C Diagnostics Introduction

11.1.4 Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.1.5 Roche Diagnostics Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Hepatitis B and C Diagnostics Introduction

11.2.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.2.5 Abbott Recent Development

11.3 Siemens

11.3.1 Siemens Company Detail

11.3.2 Siemens Business Overview

11.3.3 Siemens Hepatitis B and C Diagnostics Introduction

11.3.4 Siemens Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.3.5 Siemens Recent Development

11.4 Qiagen

11.4.1 Qiagen Company Detail

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Hepatitis B and C Diagnostics Introduction

11.4.4 Qiagen Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.4.5 Qiagen Recent Development

11.5 Abbott

11.5.1 Abbott Company Detail

11.5.2 Abbott Business Overview

11.5.3 Abbott Hepatitis B and C Diagnostics Introduction

11.5.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.5.5 Abbott Recent Development

11.6 bioMérieux

11.6.1 bioMérieux Company Detail

11.6.2 bioMérieux Business Overview

11.6.3 bioMérieux Hepatitis B and C Diagnostics Introduction

11.6.4 bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.6.5 bioMérieux Recent Development

11.7 Cepheid

11.7.1 Cepheid Company Detail

11.7.2 Cepheid Business Overview

11.7.3 Cepheid Hepatitis B and C Diagnostics Introduction

11.7.4 Cepheid Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.7.5 Cepheid Recent Development

11.8 Chembio Diagnostics

11.8.1 Chembio Diagnostics Company Detail

11.8.2 Chembio Diagnostics Business Overview

11.8.3 Chembio Diagnostics Hepatitis B and C Diagnostics Introduction

11.8.4 Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.8.5 Chembio Diagnostics Recent Development

11.9 DiaSorin

11.9.1 DiaSorin Company Detail

11.9.2 DiaSorin Business Overview

11.9.3 DiaSorin Hepatitis B and C Diagnostics Introduction

11.9.4 DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.9.5 DiaSorin Recent Development

11.10 Enzo Life Sciences

11.10.1 Enzo Life Sciences Company Detail

11.10.2 Enzo Life Sciences Business Overview

11.10.3 Enzo Life Sciences Hepatitis B and C Diagnostics Introduction

11.10.4 Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.10.5 Enzo Life Sciences Recent Development

11.11 Hologic

11.11.1 Hologic Company Detail

11.11.2 Hologic Business Overview

11.11.3 Hologic Hepatitis B and C Diagnostics Introduction

11.11.4 Hologic Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.11.5 Hologic Recent Development

11.12 MedMira

11.12.1 MedMira Company Detail

11.12.2 MedMira Business Overview

11.12.3 MedMira Hepatitis B and C Diagnostics Introduction

11.12.4 MedMira Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.12.5 MedMira Recent Development

11.13 OraSure Technologies

11.13.1 OraSure Technologies Company Detail

11.13.2 OraSure Technologies Business Overview

11.13.3 OraSure Technologies Hepatitis B and C Diagnostics Introduction

11.13.4 OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.13.5 OraSure Technologies Recent Development

11.14 Quest Diagnostics

11.14.1 Quest Diagnostics Company Detail

11.14.2 Quest Diagnostics Business Overview

11.14.3 Quest Diagnostics Hepatitis B and C Diagnostics Introduction

11.14.4 Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.14.5 Quest Diagnostics Recent Development

11.15 Quidel Corp

11.15.1 Quidel Corp Company Detail

11.15.2 Quidel Corp Business Overview

11.15.3 Quidel Corp Hepatitis B and C Diagnostics Introduction

11.15.4 Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.15.5 Quidel Corp Recent Development

11.16 Randox Laboratories

11.16.1 Randox Laboratories Company Detail

11.16.2 Randox Laboratories Business Overview

11.16.3 Randox Laboratories Hepatitis B and C Diagnostics Introduction

11.16.4 Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2018-2023)

11.16.5 Randox Laboratories Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Hepatitis B

    Table 3. Key Players of Hepatitis C

    Table 4. Global Hepatitis B and C Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Hepatitis B and C Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Hepatitis B and C Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Hepatitis B and C Diagnostics Market Share by Region (2018-2023)

    Table 8. Global Hepatitis B and C Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Hepatitis B and C Diagnostics Market Share by Region (2024-2029)

    Table 10. Hepatitis B and C Diagnostics Market Trends

    Table 11. Hepatitis B and C Diagnostics Market Drivers

    Table 12. Hepatitis B and C Diagnostics Market Challenges

    Table 13. Hepatitis B and C Diagnostics Market Restraints

    Table 14. Global Hepatitis B and C Diagnostics Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Hepatitis B and C Diagnostics Market Share by Players (2018-2023)

    Table 16. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B and C Diagnostics as of 2022)

    Table 17. Ranking of Global Top Hepatitis B and C Diagnostics Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Hepatitis B and C Diagnostics Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Hepatitis B and C Diagnostics Product Solution and Service

    Table 21. Date of Enter into Hepatitis B and C Diagnostics Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Hepatitis B and C Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2018-2023)

    Table 25. Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2024-2029)

    Table 27. Global Hepatitis B and C Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2018-2023)

    Table 29. Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2024-2029)

    Table 31. North America Hepatitis B and C Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Hepatitis B and C Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Hepatitis B and C Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Hepatitis B and C Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Hepatitis B and C Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Roche Diagnostics Company Detail

    Table 47. Roche Diagnostics Business Overview

    Table 48. Roche Diagnostics Hepatitis B and C Diagnostics Product

    Table 49. Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 50. Roche Diagnostics Recent Development

    Table 51. Abbott Company Detail

    Table 52. Abbott Business Overview

    Table 53. Abbott Hepatitis B and C Diagnostics Product

    Table 54. Abbott Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 55. Abbott Recent Development

    Table 56. Siemens Company Detail

    Table 57. Siemens Business Overview

    Table 58. Siemens Hepatitis B and C Diagnostics Product

    Table 59. Siemens Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 60. Siemens Recent Development

    Table 61. Qiagen Company Detail

    Table 62. Qiagen Business Overview

    Table 63. Qiagen Hepatitis B and C Diagnostics Product

    Table 64. Qiagen Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 65. Qiagen Recent Development

    Table 66. Abbott Company Detail

    Table 67. Abbott Business Overview

    Table 68. Abbott Hepatitis B and C Diagnostics Product

    Table 69. Abbott Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 70. Abbott Recent Development

    Table 71. bioMérieux Company Detail

    Table 72. bioMérieux Business Overview

    Table 73. bioMérieux Hepatitis B and C Diagnostics Product

    Table 74. bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 75. bioMérieux Recent Development

    Table 76. Cepheid Company Detail

    Table 77. Cepheid Business Overview

    Table 78. Cepheid Hepatitis B and C Diagnostics Product

    Table 79. Cepheid Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 80. Cepheid Recent Development

    Table 81. Chembio Diagnostics Company Detail

    Table 82. Chembio Diagnostics Business Overview

    Table 83. Chembio Diagnostics Hepatitis B and C Diagnostics Product

    Table 84. Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 85. Chembio Diagnostics Recent Development

    Table 86. DiaSorin Company Detail

    Table 87. DiaSorin Business Overview

    Table 88. DiaSorin Hepatitis B and C Diagnostics Product

    Table 89. DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 90. DiaSorin Recent Development

    Table 91. Enzo Life Sciences Company Detail

    Table 92. Enzo Life Sciences Business Overview

    Table 93. Enzo Life Sciences Hepatitis B and C Diagnostics Product

    Table 94. Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 95. Enzo Life Sciences Recent Development

    Table 96. Hologic Company Detail

    Table 97. Hologic Business Overview

    Table 98. Hologic Hepatitis B and C Diagnostics Product

    Table 99. Hologic Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 100. Hologic Recent Development

    Table 101. MedMira Company Detail

    Table 102. MedMira Business Overview

    Table 103. MedMira Hepatitis B and C Diagnostics Product

    Table 104. MedMira Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 105. MedMira Recent Development

    Table 106. OraSure Technologies Company Detail

    Table 107. OraSure Technologies Business Overview

    Table 108. OraSure Technologies Hepatitis B and C Diagnostics Product

    Table 109. OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 110. OraSure Technologies Recent Development

    Table 111. Quest Diagnostics Company Detail

    Table 112. Quest Diagnostics Business Overview

    Table 113. Quest Diagnostics Hepatitis B and C Diagnostics Product

    Table 114. Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 115. Quest Diagnostics Recent Development

    Table 116. Quidel Corp Company Detail

    Table 117. Quidel Corp Business Overview

    Table 118. Quidel Corp Hepatitis B and C Diagnostics Product

    Table 119. Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 120. Quidel Corp Recent Development

    Table 121. Randox Laboratories Company Detail

    Table 122. Randox Laboratories Business Overview

    Table 123. Randox Laboratories Hepatitis B and C Diagnostics Product

    Table 124. Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2018-2023) & (US$ Million)

    Table 125. Randox Laboratories Recent Development

    Table 126. Research Programs/Design for This Report

    Table 127. Key Data Information from Secondary Sources

    Table 128. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Hepatitis B and C Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Hepatitis B and C Diagnostics Market Share by Type: 2022 VS 2029

    Figure 3. Hepatitis B Features

    Figure 4. Hepatitis C Features

    Figure 5. Global Hepatitis B and C Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Hepatitis B and C Diagnostics Market Share by Application: 2022 VS 2029

    Figure 7. Immunodiagnostics Case Studies

    Figure 8. Nucleic Acid Test (NAT) Case Studies

    Figure 9. Hepatitis B and C Diagnostics Report Years Considered

    Figure 10. Global Hepatitis B and C Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 11. Global Hepatitis B and C Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Hepatitis B and C Diagnostics Market Share by Region: 2022 VS 2029

    Figure 13. Global Hepatitis B and C Diagnostics Market Share by Players in 2022

    Figure 14. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B and C Diagnostics as of 2022)

    Figure 15. The Top 10 and 5 Players Market Share by Hepatitis B and C Diagnostics Revenue in 2022

    Figure 16. North America Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 17. North America Hepatitis B and C Diagnostics Market Share by Country (2018-2029)

    Figure 18. United States Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. Canada Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Europe Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Hepatitis B and C Diagnostics Market Share by Country (2018-2029)

    Figure 22. Germany Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. France Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. U.K. Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Italy Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Russia Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Nordic Countries Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Asia-Pacific Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Region (2018-2029)

    Figure 30. China Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Japan Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. South Korea Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Southeast Asia Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. India Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Australia Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Latin America Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Hepatitis B and C Diagnostics Market Share by Country (2018-2029)

    Figure 38. Mexico Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Brazil Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Middle East & Africa Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Country (2018-2029)

    Figure 42. Turkey Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Saudi Arabia Hepatitis B and C Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Roche Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 45. Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 46. Siemens Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 47. Qiagen Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 48. Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 49. bioMérieux Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 50. Cepheid Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 51. Chembio Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 52. DiaSorin Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 53. Enzo Life Sciences Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 54. Hologic Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 55. MedMira Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 56. OraSure Technologies Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 57. Quest Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 58. Quidel Corp Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 59. Randox Laboratories Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2018-2023)

    Figure 60. Bottom-up and Top-down Approaches for This Report

    Figure 61. Data Triangulation

    Figure 62. Key Executives Interviewed